Current Protein Identity:P04578 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1AIK HIV GP41 CORE STRUCTURE Deposited 1997-04-20 Assembly 1 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain C 623–656(34 aa) Fragment:PROTEASE-RESISTANT CORE
Chain N 544–579(36 aa) Fragment:PROTEASE-RESISTANT CORE
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6;A 10 MG/ML STOCK WAS DILUTED 1:1 IN A SITTING DROP WITH 80 MM NH4CL, 20% PEG200, AND 50% ISOPROPANOL, AND THEN ALLOWED TO EQUILIBRATE AGAINST 80 MM NH4CL, 20% PEG200, AND 30% ISOPROPANOL., pH 6.0, vapor diffusion - sitting drop
Resolution 2.00 Å R-free 0.266
1DF4 INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSION Deposited 1999-11-17 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 546–579(34 aa) Fragment:RESIDUES 1 - 34 AND 41 - 68 CONNECTED BY A SIX-RESIDUE LINKER (SER-GLY-GLY-ARG- GLY-GLY)
Chain A 628–655(28 aa) Fragment:RESIDUES 1 - 34 AND 41 - 68 CONNECTED BY A SIX-RESIDUE LINKER (SER-GLY-GLY-ARG- GLY-GLY)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;SODIUM CITRATE, AMMONIUM DIHYDROGEN PHOSPHATE, BETA-OG, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.45 Å R-free 0.245
1DF5 INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSION Deposited 1999-11-17 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 546–579(34 aa) Fragment:RESIDUES 1 - 34 AND 41 - 68 CONNECTED BY A SIX-RESIDUE LINKER (SER-GLY-GLY-ARG-GLY-GLY)
Chain A 628–655(28 aa) Fragment:RESIDUES 1 - 34 AND 41 - 68 CONNECTED BY A SIX-RESIDUE LINKER (SER-GLY-GLY-ARG-GLY-GLY)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;Potassium sodium tartrate, SDS, sodium hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.70 Å R-free 0.315
1DLB HELICAL INTERACTIONS IN THE HIV-1 GP41 CORE REVEALS STRUCTURAL BASIS FOR THE INHIBITORY ACTIVITY OF GP41 PEPTIDES Deposited 1999-12-09 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 546–579(34 aa) Fragment:RESIDUES 1 - 34 AND 41 - 68 CONNECTED BY A SIX-RESIDUE LINKER (SER-GLY-GLY-ARG- GLY-GLY)
Chain A 628–655(28 aa) Fragment:RESIDUES 1 - 34 AND 41 - 68 CONNECTED BY A SIX-RESIDUE LINKER (SER-GLY-GLY-ARG- GLY-GLY)
Mutation:Q65L Mutation:Q65L No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;PEG 4000, AMMONIUM SULPHATE, SODIUM ACETATE, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K
Resolution 2.00 Å R-free 0.243
1G9M HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B Deposited 2000-11-24 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain G 83–127(45 aa) Fragment:CORE
Chain G 195–297(103 aa) Fragment:CORE
Chain G 330–492(163 aa) Fragment:CORE
Mutation:VARIABLE LOOPS SUBSTITUTED Mutation:VARIABLE LOOPS SUBSTITUTED Mutation:VARIABLE LOOPS SUBSTITUTED NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 IPA ISOPROPYL ALCOHOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.4;293 K;VAPOUR DIFFUSION CRYSTALLIZATION: 0.5 UL OF PROTEIN (~10MG/ML IN 350 MM NACL, 5 MM TRISCL PH 7.0) + 0.4 UL OF 0.1 M NACITRATE, 0.02 M NAHEPES, 10% ISOPROPANOL, 10.5% MONOMETHYL-PEG 5000, 0.0075% SEAPREP AGAROSE, PH 6.4 OVER A RESERVOIR OF 0.35 M NACL, 0.1 M NACITRATE, 0.02 M NAHEPES, 10% ISOPROPANOL, 10.5% MONOMETHYL-PEG 5000, PH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.20 Å R-free 0.330
1GC1 HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY Deposited 1998-06-15 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain G 83–127(45 aa) Fragment:CORE
Chain G 195–297(103 aa) Fragment:CORE
Chain G 330–492(163 aa) Fragment:CORE
Mutation:(GARS) SUBSTITUTION AT THE N TERMINUS, GLY ALA GLY SUBSTITUTIONS FOR THE V1/V2 AND V3 LOOPS Mutation:(GARS) SUBSTITUTION AT THE N TERMINUS, GLY ALA GLY SUBSTITUTIONS FOR THE V1/V2 AND V3 LOOPS Mutation:(GARS) SUBSTITUTION AT THE N TERMINUS, GLY ALA GLY SUBSTITUTIONS FOR THE V1/V2 AND V3 LOOPS NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7;VAPOUR DIFFUSION CRYSTALLIZATION: 0.5 UL OF PROTEIN (~10MG/ML IN 350 MM NACL, 5 MM TRISCL PH 7.0) + 0.4 UL OF 0.1 M NACITRATE, 0.02 M NAHEPES, 10% ISOPROPANOL, 10.5% MONOMETHYL-PEG 5000, 0.0075% SEAPREP AGAROSE, PH 6.4 OVER A RESERVOIR OF 0.35 M NACL, 0.1 M NACITRATE, 0.02 M NAHEPES, 10% ISOPROPANOL, 10.5% MONOMETHYL-PEG 5000, PH 6.4, vapor diffusion
Resolution 2.50 Å R-free 0.302
1GZL Crystal structure of C14linkmid/IQN17: a cross-linked inhibitor of HIV-1 entry bound to the gp41 hydrophobic pocket Deposited 2002-05-23 Assembly 1 Insufficient information Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 565–581(17 aa) Fragment:GP41 HYDROPHOBIC POCKET, RESIDUES 565-581, GCN4, RESIDUES 249-276
Chain C 628–639(12 aa) Fragment:RESIDUES 628-639
Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:YES CL CHLORIDE ION × 3 N2P PENTANE-1,5-DIAMINE × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.6;16% ISOPROPANOL, 0.1 M TRIS, PH 8.6, 1 M (NH4)2SO4
Resolution 1.80 Å R-free 0.243
1GZL Crystal structure of C14linkmid/IQN17: a cross-linked inhibitor of HIV-1 entry bound to the gp41 hydrophobic pocket Deposited 2002-05-23 Assembly 2 Insufficient information Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain B 565–581(17 aa) Fragment:GP41 HYDROPHOBIC POCKET, RESIDUES 565-581, GCN4, RESIDUES 249-276
Chain D 628–639(12 aa) Fragment:RESIDUES 628-639
Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:YES CL CHLORIDE ION × 3 N2P PENTANE-1,5-DIAMINE × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.6;16% ISOPROPANOL, 0.1 M TRIS, PH 8.6, 1 M (NH4)2SO4
Resolution 1.80 Å R-free 0.243
1K33 Crystal structure analysis of the gp41 core mutant Deposited 2001-10-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 546–579(34 aa) Fragment:gp41 ectodomain core
Chain A 628–655(28 aa) Fragment:gp41 ectodomain core
Mutation:I48A Mutation:I48A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
Resolution 1.75 Å R-free 0.226
1K34 Crystal structure analysis of gp41 core mutant Deposited 2001-10-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 546–579(34 aa) Fragment:gp41 ectodomain core
Chain A 628–655(28 aa) Fragment:gp41 ectodomain core
Mutation:I55A Mutation:I55A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
Resolution 1.88 Å R-free 0.216
1MZI Solution ensemble structures of HIV-1 gp41 2F5 mAb epitope Deposited 2002-10-08 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 659–671(13 aa) Fragment:13 residues 2F5 epitope
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.5;278 K;Ionic strength (raw mmCIF value) 50mM phosphate buffer;Pressure ambient
NMR sample composition 1.5mM peptide, 50mM phosphate buffer, pH 6.5 | 95% H2O/5% D2O
NMR sample composition 1.5mM peptide, 50mM phosphate buffer, pH 6.5 | 100% D2O
Resolution not provided
1RZJ HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B Deposited 2003-12-24 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain G 195–492(298 aa) Fragment:CORE
Mutation:VARIABLE LOOPS SUBSTITUTED NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 IPA ISOPROPYL ALCOHOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.4;293 K;0.5 UL OF PROTEIN (~10MG/ML IN 350 MM NACL, 5 MM TRISCL PH 7.0) + 0.4 UL OF 0.1 M NACITRATE, 0.02 M NAHEPES, 10% ISOPROPANOL, 10.5% MONOMETHYL-PEG 5000, 0.0075% SEAPREP AGAROSE, PH 6.4 OVER A RESERVOIR OF 0.35 M NACL, 0.1 M NACITRATE, 0.02 M NAHEPES, 10% ISOPROPANOL, 10.5% MONOMETHYL-PEG 5000, PH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.20 Å R-free 0.323
2CMR Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to the gp41 inner-core mimetic 5-helix Deposited 2006-05-11 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 543–582(40 aa) Fragment:5-HELIX, RESIDUES 543-582 AND 625-662
Chain A 625–662(38 aa) Fragment:5-HELIX, RESIDUES 543-582 AND 625-662
Not recorded GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;18% (W/V) PEG 4000, 0.2 M TRI-SODIUM CITRATE DIHYDRATE, 0.1 M TRIS-HCL / PH = 8.5
Resolution 2.00 Å R-free 0.258
2ME1 HIV-1 gp41 clade B double alanine mutant Membrane Proximal External Region peptide in DPC micelle Deposited 2013-09-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 657–683(27 aa) Fragment:membrane proximal external region (UNP residues 657-683)
Mutation:N671A/N674A No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.6;308 K;Ionic strength (raw mmCIF value) 0;Pressure ambient
NMR sample composition 1 mM [U-100% 13C; U-100% 15N] MPER-HXB2-AA, 100 mM [U-100% 2H] DPC, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 1 mM [U-100% 15N] MPER-HXB2-AA, 100 mM [U-100% 2H] DPC, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 1 mM MPER-HXB2-AA, 100 mM [U-100% 2H] DPC, 100% D2O | 100% D2O
NMR sample composition 1 mM [U-100% 13C; U-100% 15N] MPER-HXB2-AA, 100 mM [U-100% 2H] DPC, 20 mg/mL DNA nanotube, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
2MG1 NMR assignment and structure of a peptide derived from the trans-membrane region of HIV-1 gp41 in the presence of hexafluoroisopropanol Deposited 2013-10-24 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 683–704(22 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 7;298 K;Ionic strength (raw mmCIF value) 2;Pressure ambient
NMR sample composition 0.5 mM TMDp, 67.5 % H2O, 7.5 % [U-100% 2H] D2O, 25 % hexafluoroisopropanol, 2 mM HEPES, 0.1 mM DSS, hexafluoroisopropanol/water | hexafluoroisopropanol/water
Resolution not provided
2NY7 HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12 Deposited 2006-11-20 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain G 176–492(317 aa) Fragment:CORE
Mutation:M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 13 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.30 Å R-free 0.255
2NY7 HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12 Deposited 2006-11-20 Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain G 176–492(317 aa) Fragment:CORE
Mutation:M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 26 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.30 Å R-free 0.255
2NY7 HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12 Deposited 2006-11-20 Assembly 3 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain G 176–492(317 aa) Fragment:CORE
Mutation:M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 26 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.30 Å R-free 0.255
2NY7 HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12 Deposited 2006-11-20 Assembly 4 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain G 176–492(317 aa) Fragment:CORE
Mutation:M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 26 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.30 Å R-free 0.255
2NY7 HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12 Deposited 2006-11-20 Assembly 5 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain G 176–492(317 aa) Fragment:CORE
Mutation:M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 26 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.30 Å R-free 0.255
2PV6 HIV-1 gp41 Membrane Proximal Ectodomain Region peptide in DPC micelle Deposited 2007-05-09 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 662–683(22 aa) Fragment:residues 662-683
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.6;308 K;Ionic strength (raw mmCIF value) no salt;Pressure ambient
NMR sample composition 1mM U-15N,13C MPER + 100mM d38 DPC, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 1mM U-15N MPER + 100mM d38 DPC, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 1mM unlabeled MPER + 100mM d38 DPC, 100% D2O | 100% D2O
Resolution not provided
2X7R Crystal structure of a late fusion intermediate of HIV-1 gp41 Deposited 2010-03-03 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 629–683(55 aa) Fragment:EXTRA CELLULAR DOMAIN, RESIDUES 629-683
Chain N 528–581(54 aa) Fragment:EXTRA CELLULAR DOMAIN, RESIDUES 534-581
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;0.1M CITRIC ACID PH 6, 60% MPD
Resolution 2.00 Å R-free 0.214
2X7R Crystal structure of a late fusion intermediate of HIV-1 gp41 Deposited 2010-03-03 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 528–581(54 aa) Fragment:EXTRA CELLULAR DOMAIN, RESIDUES 534-581
Chain E 629–683(55 aa) Fragment:EXTRA CELLULAR DOMAIN, RESIDUES 629-683
Not recorded NA SODIUM ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;0.1M CITRIC ACID PH 6, 60% MPD
Resolution 2.00 Å R-free 0.214
2X7R Crystal structure of a late fusion intermediate of HIV-1 gp41 Deposited 2010-03-03 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 528–581(54 aa) Fragment:EXTRA CELLULAR DOMAIN, RESIDUES 534-581
Chain B 629–683(55 aa) Fragment:EXTRA CELLULAR DOMAIN, RESIDUES 629-683
Not recorded NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;0.1M CITRIC ACID PH 6, 60% MPD
Resolution 2.00 Å R-free 0.214
2XRA crystal structure of the HK20 Fab in complex with a gp41 mimetic 5- Helix Deposited 2010-09-13 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 543–582(40 aa) Fragment:5-HELIX INNER-CORE MIMETIC COMPRISED OF REPEATS OF RESIDUES 543-582 AND 625-662
Chain A 625–662(38 aa) Fragment:5-HELIX INNER-CORE MIMETIC COMPRISED OF REPEATS OF RESIDUES 543-582 AND 625-662
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;0.1 M HEPES PH 7.5, 0.2 M AMMONIUM SULPHATE, 25% PEG 3350 (W/V)
Resolution 2.30 Å R-free 0.279
2ZZO Crystal structure of the complex between GP41 fragment N36 and fusion inhibitor C34/S138A Deposited 2009-02-20 Assembly 1 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain C 628–661(34 aa) Fragment:FUSION INHIBITOR PEPTIDE C34, UNP residues 628-661
Chain N 546–581(36 aa) Fragment:GP41 FRAGMENT N36, UNP residues 546-581
Mutation:S138A Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 4;293 K;100MM SODIUM ACETATE BUFFER, PH4.0, 400MM MAGNESIUM CHLORIDE, 12% ETHANOL, pH 4.00, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.20 Å R-free 0.283
3DNL Molecular structure for the HIV-1 gp120 trimer in the b12-bound state Deposited 2008-07-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 90–124(35 aa) Fragment:Core: Residues 90-124
Chain B 198–297(100 aa) Fragment:Core: Residues 198-396
Chain B 330–396(67 aa) Fragment:Core: Residues 198-396
Chain C 410–492(83 aa) Fragment:Core: Residues 410-492
Chain D 90–124(35 aa) Fragment:Core: Residues 90-124
Chain E 198–297(100 aa) Fragment:Core: Residues 198-396
Chain E 330–396(67 aa) Fragment:Core: Residues 198-396
Chain F 410–492(83 aa) Fragment:Core: Residues 410-492
Chain G 90–124(35 aa) Fragment:Core: Residues 90-124
Chain H 198–297(100 aa) Fragment:Core: Residues 198-396
Chain H 330–396(67 aa) Fragment:Core: Residues 198-396
Chain I 410–492(83 aa) Fragment:Core: Residues 410-492
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 0.01 M Tris-HCl, 0.1 M NaCl, 1 mM EDTA;pH 7.2;0.01 M Tris-HCl, 0.1 M NaCl, 1 mM EDTA
cryo-EM vitrification conditions Cryogen ETHANE;Ethane 77K 100%RH Vitrobot
Resolution 20.00 Å
3DNN Molecular structure for the HIV-1 gp120 trimer in the unliganded state Deposited 2008-07-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 90–124(35 aa) Fragment:Core: Residues 90-124
Chain B 198–297(100 aa) Fragment:Core: Residues 198-396
Chain B 330–396(67 aa) Fragment:Core: Residues 198-396
Chain C 410–492(83 aa) Fragment:Core: Residues 410-492
Chain D 90–124(35 aa) Fragment:Core: Residues 90-124
Chain E 198–297(100 aa) Fragment:Core: Residues 198-396
Chain E 330–396(67 aa) Fragment:Core: Residues 198-396
Chain F 410–492(83 aa) Fragment:Core: Residues 410-492
Chain G 90–124(35 aa) Fragment:Core: Residues 90-124
Chain H 198–297(100 aa) Fragment:Core: Residues 198-396
Chain H 330–396(67 aa) Fragment:Core: Residues 198-396
Chain I 410–492(83 aa) Fragment:Core: Residues 410-492
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 0.01 M Tris-HCl, 0.1 M NaCl, 1 mM EDTA;pH 7.2;0.01 M Tris-HCl, 0.1 M NaCl, 1 mM EDTA
cryo-EM vitrification conditions Cryogen ETHANE;Ethane 77K 100%RH Vitrobot
Resolution 20.00 Å
3DNO Molecular structure for the HIV-1 gp120 trimer in the CD4-bound state Deposited 2008-07-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 90–124(35 aa) Fragment:Core: Residues 90-124
Chain B 198–297(100 aa) Fragment:Core: Residues 198-396
Chain B 330–396(67 aa) Fragment:Core: Residues 198-396
Chain C 410–492(83 aa) Fragment:Core: Residues 410-492
Chain D 90–124(35 aa) Fragment:Core: Residues 90-124
Chain E 198–297(100 aa) Fragment:Core: Residues 198-396
Chain E 330–396(67 aa) Fragment:Core: Residues 198-396
Chain F 410–492(83 aa) Fragment:Core: Residues 410-492
Chain G 90–124(35 aa) Fragment:Core: Residues 90-124
Chain H 198–297(100 aa) Fragment:Core: Residues 198-396
Chain H 330–396(67 aa) Fragment:Core: Residues 198-396
Chain I 410–492(83 aa) Fragment:Core: Residues 410-492
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer 0.01 M Tris-HCl, 0.1 M NaCl, 1 mM EDTA;pH 7.2;0.01 M Tris-HCl, 0.1 M NaCl, 1 mM EDTA
cryo-EM vitrification conditions Cryogen ETHANE;Ethane 77K 100%RH Vitrobot
Resolution 20.00 Å
3J70 Model of gp120, including variable regions, in complex with CD4 and 17b Deposited 2014-04-22 Assembly 1 Protein heterocomplex Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count
Chain D 31–500(470 aa) Fragment:UNP residues 31-500
Chain P 31–500(470 aa) Fragment:UNP residues 31-500
Chain U 31–500(470 aa) Fragment:UNP residues 31-500
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 20.00 Å
3TYG Crystal structure of broad and potent HIV-1 neutralizing antibody PGT128 in complex with a glycosylated engineered gp120 outer domain with miniV3 (eODmV3) Deposited 2011-09-25 Assembly 1 Insufficient information Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 412–419(8 aa)
Chain A 445–477(33 aa)
Chain A 254–297(44 aa)
Chain A 330–401(72 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8;277 K;24% PEG 3350, 0.29M CaCl2, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution 3.25 Å R-free 0.257
5C0R Crystal Structure of a Generation 3 Influenza Hemagglutinin Stabilized Stem Complexed with the Broadly Neutralizing Antibody C179 Deposited 2015-06-12 Assembly 1 Insufficient information Heteromer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 628–654(27 aa) Fragment:UNP Q6WG00 residues 18-49, 328-402, 436-517, UNP P04578 residues 546-577, 628-654 and UNP D9IEJ2 residues 458-485
Chain A 546–577(32 aa) Fragment:UNP Q6WG00 residues 18-49, 328-402, 436-517, UNP P04578 residues 546-577, 628-654 and UNP D9IEJ2 residues 458-485
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;15% (w/v) PEG 1500, 5% (v/v) MPD, 200 mM ammonium chloride, 100 mM Tris, pH 8.5
Resolution 3.19 Å R-free 0.251
5C0S Crystal structure of a generation 4 influenza hemagglutinin stabilized stem in complex with the broadly neutralizing antibody CR6261 Deposited 2015-06-12 Assembly 1 Insufficient information Heteromer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 628–654(27 aa) Fragment:UNP Q6WG00 residues 18-49, 328-402, 436-517, UNP P04578 residues 546-577, 628-654 and UNP D9IEJ2 residues 458-485
Chain A 546–577(32 aa) Fragment:UNP Q6WG00 residues 18-49, 328-402, 436-517, UNP P04578 residues 546-577, 628-654 and UNP D9IEJ2 residues 458-485
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;7% (w/v) PEG 4000, 4.5% (v/v) isopropanol, 100 mM imidazole, pH 6.5
Resolution 4.30 Å R-free 0.310
5HM1 Llama VHH 2E7 in complex with gp41 Deposited 2016-01-15 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 582–596(15 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;0.1 M Hepes pH 7.0 30% PEG 6000
Resolution 2.96 Å R-free 0.249
5HM1 Llama VHH 2E7 in complex with gp41 Deposited 2016-01-15 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 582–596(15 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;0.1 M Hepes pH 7.0 30% PEG 6000
Resolution 2.96 Å R-free 0.249
5HM1 Llama VHH 2E7 in complex with gp41 Deposited 2016-01-15 Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 582–596(15 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;0.1 M Hepes pH 7.0 30% PEG 6000
Resolution 2.96 Å R-free 0.249
5KA5 HIV-1 gp41 variant V549E resistance mutation Deposited 2016-06-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 543–582(40 aa) Fragment:UNP residues 543-582 and 625-661 linked via GGRGG
Chain A 625–661(37 aa) Fragment:UNP residues 543-582 and 625-661 linked via GGRGG
Mutation:V549E Mutation:V549E No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.5;291 K;3M Sodium chloride, 0.1M Sodium Acetate Sample concentration: 6 mg/ml
Resolution 1.80 Å R-free 0.223
5KA6 HIV-1 gp41 variant Q552R and L555M resistance mutations Deposited 2016-06-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 543–582(40 aa) Fragment:UNP residues 543-582 and 625-661 linked via GGRGG
Chain A 625–661(37 aa) Fragment:UNP residues 543-582 and 625-661 linked via GGRGG
Chain B 543–582(40 aa) Fragment:UNP residues 543-582 and 625-661 linked via GGRGG
Chain B 625–661(37 aa) Fragment:UNP residues 543-582 and 625-661 linked via GGRGG
Chain C 543–582(40 aa) Fragment:UNP residues 543-582 and 625-661 linked via GGRGG
Chain C 625–661(37 aa) Fragment:UNP residues 543-582 and 625-661 linked via GGRGG
Mutation:Q552R, L555M Mutation:Q552R, L555M Mutation:Q552R, L555M Mutation:Q552R, L555M Mutation:Q552R, L555M Mutation:Q552R, L555M No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;20% PEG 8000, 0.3M Calcium Acetate, 0.1M Sodium Cacodylate Sample concentration: 6.35 mg/ml
Resolution 1.85 Å R-free 0.278
6DLN Oligomeric Structure of the HIV gp41 MPER-TMD in Phospholipid Bilayers Deposited 2018-06-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 665–703(39 aa) Fragment:residues 665-703
Chain B 665–703(39 aa) Fragment:residues 665-703
Chain C 665–703(39 aa) Fragment:residues 665-703
Not recorded No recorded non-water small molecule SOLID-STATE NMR
NMR measurement conditions pH 7.5;263 K;Pressure 1
NMR measurement conditions pH 7.5;233 K;Pressure 1
NMR sample composition 33 % w/w 4-19F-F699 HIV gp41 MPER-TMD, reconstituted into the virus mimetic membrane (POPC:POPE:POPS:sphingomyelin: cholesterol = 30:15:15:10:30), 10 mM HEPES buffer pH 7.5 | 10 mM HEPES buffer pH 7.5
NMR sample composition 33 % w/w [U-13C; U-15N]-L684,I686, G694, 19F-5F-W678, 19F-4F-F699 HIV gp41 MPER-TMD, reconstituted into the virus mimetic membrane (POPC:POPE:POPS:sphingomyelin: cholesterol = 30:15:15:10:30), 10 mM HEPES buffer pH 7.5 | 10 mM HEPES buffer pH 7.5
NMR sample composition 33 % w/w [U-13C; U-15N]-L669,I686, A700, 13C'-G694, 19F-5F-W680 HIV gp41 MPER-TMD, reconstituted into the virus mimetic membrane (POPC:POPE:POPS:sphingomyelin: cholesterol = 30:15:15:10:30), 10 mM HEPES buffer pH 7.5 | 10 mM HEPES buffer pH 7.5
Resolution not provided
6PSA PIE12 D-PEPTIDE AGAINST HIV ENTRY (IN COMPLEX WITH IQN17 Q577R RESISTANCE MUTANT) Deposited 2019-07-12 Assembly 1 Insufficient information Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 565–581(17 aa) Fragment:GP41 HYDROPHOBIC POCKET, RESIDUES 565-581, GCN4, RESIDUES 249-276
Mutation:Q577R Non-standard monomer:Yes (specific site not provided by mmCIF) CL CHLORIDE ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.6;294 K;HAMPTON RESEARCH SALT RX SCREEN, CONDITION B4 - 1.8M AMMONIUM CITRATE DIBASIC, 0.1 M SODIUM ACETATE TRIHYDRATE, PH 4.6
Resolution 1.30 Å R-free 0.217
8TQ7 Crystal structure of Fab.34.2.12 in complex with MHC-I (H2-Dd) Deposited 2023-08-06 Assembly 1 Protein heterocomplex Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain E 311–320(10 aa) Fragment:HV1: HIV-1 P18-I10 (UNP residues 311-320)
Chain P 311–320(10 aa) Fragment:HV1: HIV-1 P18-I10 (UNP residues 311-320)
Not recorded EDO 1,2-ETHANEDIOL × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;12% PEG8000, 0.1 M MES, pH 6.5
Resolution 2.80 Å R-free 0.271
8TQ8 Crystal structure of Fab.34.5.8 in complex with MHC-I (H2-Dd) Deposited 2023-08-06 Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain P 311–320(10 aa) Fragment:HV1: HIV-1 P18-I10 (UNP residues 311-320)
Not recorded GOL GLYCEROL × 3 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;291 K;18% PEG4000, 0.1 M MES, pH 6.0, 0.12 M calcium acetate
Resolution 2.69 Å R-free 0.242
8TQ8 Crystal structure of Fab.34.5.8 in complex with MHC-I (H2-Dd) Deposited 2023-08-06 Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain E 311–320(10 aa) Fragment:HV1: HIV-1 P18-I10 (UNP residues 311-320)
Not recorded GOL GLYCEROL × 2 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;291 K;18% PEG4000, 0.1 M MES, pH 6.0, 0.12 M calcium acetate
Resolution 2.69 Å R-free 0.242
8TQ9 Crystal structure of Fab.S19.8 in complex with MHC-I (H2-Dd) Deposited 2023-08-06 Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain P 311–320(10 aa) Fragment:HV1: HIV-1 P18-I10 (UNP residues 311-320)
Not recorded SO4 SULFATE ION × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;291 K;0.5 M ammonium sulfate, 0.1 M sodium citrate, pH 5.6, 1.0 M lithium sulfate
Resolution 2.90 Å R-free 0.240
8W2Y Structure and interactions of HIV-1 gp41 CHR-NHR reverse hairpin constructs reveal molecular determinants of antiviral activity Deposited 2024-02-21 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 542–591(50 aa)
Not recorded GOL GLYCEROL × 3 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 6.4;293 K;0.1M lithium sulfate, 0.1M sodium citrate trihydrate at pH 6.4 and 25% PEG-1500
Resolution 1.63 Å R-free 0.291
8W32 Structure and interactions of HIV-1 gp41 CHR-NHR reverse hairpin constructs reveal molecular determinants of antiviral activity Deposited 2024-02-21 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 542–591(50 aa)
Not recorded SO4 SULFATE ION × 3 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 6.4;293 K;0.1M lithium sulfate, 0.1M sodium citrate trihydrate at pH 6.4 and 25% PEG-1500
Resolution 1.72 Å R-free 0.290
8W37 Structure and interactions of HIV-1 gp41 CHR-NHR reverse hairpin constructs reveal molecular determinants of antiviral activity Deposited 2024-02-22 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 542–591(50 aa)
Not recorded SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 6.4;293 K;0.1M lithium sulfate, 0.1M sodium citrate trihydrate at pH 6.4 and 25% PEG-1500
Resolution 2.07 Å R-free 0.268
9ARN Structure and interactions of HIV-1 gp41 CHR-NHR reverse hairpin constructs reveal molecular determinants of antiviral activity Deposited 2024-02-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 542–591(50 aa) Fragment:residues 542-591 (Uniprot numbering), plus N-terminal extension
Not recorded SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 6.4;293 K;0.1M lithium sulfate, 0.1M sodium citrate trihydrate at pH 6.4 and 25% PEG-1500
Resolution 1.41 Å R-free 0.291
9ARP Structure and interactions of HIV-1 gp41 CHR-NHR reverse hairpin constructs reveal molecular determinants of antiviral activity Deposited 2024-02-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 542–591(50 aa) Fragment:residues 542-591 (Uniprot numbering), with N-terminal extension
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;200mM ammonium sulfate, 100mM sodium acetate, 25% w/v PEG 4000 at pH 4.6
Resolution 2.04 Å R-free 0.369
9ARP Structure and interactions of HIV-1 gp41 CHR-NHR reverse hairpin constructs reveal molecular determinants of antiviral activity Deposited 2024-02-23 Assembly 2 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain B 542–591(50 aa) Fragment:residues 542-591 (Uniprot numbering), with N-terminal extension
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;200mM ammonium sulfate, 100mM sodium acetate, 25% w/v PEG 4000 at pH 4.6
Resolution 2.04 Å R-free 0.369